Sam Fazeli, director of research at Bloomberg Intelligence, said in a best-case scenario that the drug could only be launched in 2028, at which stage multiple competitors might be available. Outpaced by rivals Danuglipron was designed as a needle-free alternative to popular weight-loss shots from Novo Nordisk A/S and Eli Lilly & Co
It Supports Long-Term Fat Loss Unlike fad diets, semaglutide improves metabolic function and hunger signaling, helping the body shift into a fat-burning rhythm that is easier to maintain
Healthcare providers may recommend GLP-1 medications for those struggling with long-term weight management when other methods are ineffective
For example, pairing GLP-1 with glucagon aims to merge GLP-1s strong appetite-suppressing and glucose-lowering effects with glucagons lipolytic and thermogenic actions (possibly mediated indirectly through factors such as FGF21)
In this case, the R 2 value is calculated as 0.9828, indicating that the model accounts for approximately 98.28% of the variation observed in the data